Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does alendronate improve bone mineral density in patients with RA treated with glucocorticoids?

Nature Clinical Practice Rheumatology volume 2, pages 412–413 (2006)Cite this article

boxed-textLems WF et al. (2006) Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Osteoporos Int 17: 716–723

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Van Staa TP et al. (2003) Bone density threshold and other predictors of vertebral fractures in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48: 3224–3229

    Article  CAS  Google Scholar 

  2. Lane NE et al. (2006) Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 21: 466–476

    Article  CAS  Google Scholar 

  3. Balooch G et al. (2005) Risedronate maintains bone matrix mechanical properties and mineralization in a glucocorticoid-induced osteoporosis mouse and human study. Presented at the American Society for Mineral and Bone Research Annual Meeting, 23–27 September 2005, Nashville, Tennessee

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Director and Endowed Professor of the Aging Center, Medicine and Rheumatology, at the University of California at Davis Medical Center in Sacramento, CA, USA

    Nancy E Lane

Authors
  1. Nancy E Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nancy E Lane.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lane, N. Does alendronate improve bone mineral density in patients with RA treated with glucocorticoids?. Nat Rev Rheumatol 2, 412–413 (2006). https://doi.org/10.1038/ncprheum0248

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0248

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing